CVS Health (NYSE:CVS) Price Target Cut to $77.00

CVS Health (NYSE:CVS – Free Report) had its target price lowered by Bank of America from $95.00 to $77.00 in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a buy rating on the pharmacy operator’s stock. A number of other analysts also recently issued reports on CVS. Truist […]

Related Keywords

United States ,America ,Prems Shah ,Edwardj Ludwig , ,Health Care ,Health Corporation ,Northern Trust Corp ,Capital International Investors ,Vanguard Group Inc ,Health Company Profile ,Health Announces Dividend ,Cantor Fitzgerald ,Goldman Sachs Group ,Health Price Performance ,Health Daily ,Health Services ,Cvs Health ,Securities Exchange Commission ,Free Report ,Moderate Buy ,Get Free Report ,Director Edward ,Exchange Commission ,World Investors ,International Investors ,Trust Corp ,Health Care Benefits ,Consumer Wellness ,Nyse Cvs ,Cvs ,Retail Wholesale ,12665010 ,Lower Price Target ,Bank Of America Co ,